Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Taiho Pharmaceutical Co., Ltd.)"
Count: 58
Selected: 0
NCT IDTitle
NCT02322593Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer
NCT00721916Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer
NCT00284258Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
NCT04999761AB122 Platform Study
NCT04825431Mass Balance Study of [14C] TAS-205 in Healthy Volunteers
NCT04587908A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy(REACH-DMD)
NCT04512053A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence
NCT03605251Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.
NCT03175029Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.
NCT02906683Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence
NCT02752048A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy
NCT02562807A Study of TAS-303 in Female Patients With Stress Urinary Incontinence
NCT02261532A Phase I Study of TAS-102 in Solid Tumors
NCT02246478A Study of TAS-205 for Duchenne Muscular Dystrophy
NCT01955837Study of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in Asia
NCT01610479A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors
NCT01465464Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma
NCT00891332Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer
NCT00824161Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer
NCT00784290Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma
NCT00770874Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer
NCT00737360Phase II Study of TAS-106 to Treat Head and Neck Cancer
NCT00661167Phase II Study of ABI-007 for Gastric Cancer
NCT00569790Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer
NCT00569699Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)
NCT00569335Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer
NCT00498225Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer
NCT00359567Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy
NCT00229424Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -
NCT00202969Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
NCT00152243A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)
NCT00152230A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)
NCT00152217Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
NCT00152191A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)
NCT00152178The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)
NCT00150670Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer
NCT01904253A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
NCT04074343TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma
NCT02943733Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs
NCT02090153Study of S-1 Plus LV for Advanced Gastric Cancer
NCT02024841Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis
NCT01824459S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients
NCT01811277SOX Sequential S-1 in Advanced Biliary Tract Carcinoma(BTC)and Pancreatic Cancer
NCT01679340A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery
NCT01534546Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection
NCT01227239Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting
NCT00752011Phase I Study of TAS-106 in Combo With Carboplatin
NCT00639327Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
NCT00602745S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen
NCT00166543Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer